ASX/EPN (ASX/EPN)

Australian Securities Exchange: ASX/EPN · AUD

A$0.02

-0.00 (-4.8%)· Recorded snapshot

Market cap	7.8M
Revenue (ttm)	13.6M
Net income (ttm)	64.4K
EPS (ttm)	A$0.00
Shares out	389.1M
P/E (trailing)	148.1x
Volume	58,030
Beta	0.63

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.6M
Net income (ttm): 64.4K
EPS (ttm): A$0.00
P/E (trailing): 148.1x
Market cap: 7.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E148.1

P25 n/aP50 n/aP75 n/a

ROE50.3

P25 n/aP50 n/aP75 n/a

ROIC-8.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/EPN indicators

Market & fundamental data

Available fields

165

Groups with data

Currency

AUD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-12-01
Enterprise value	AUD 15.2M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2016
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	AU0000137598
Last earnings date	2026-02-26
Last refreshed	2026-10-30
Market cap	AUD 7.8M
Next earnings date	2026-12-01
Price	AUD 0.02
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-30
Symbol	asx/EPN
Website	https://epsilonhealthcare.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	0.68%
EV/Earnings	235.86x
EV/FCF	43.73x
EV/Sales	1.12x
FCF / EV yield	2.29%
FCF yield	4.46%
Graham number	0.0055
Graham upside	-72.5%
P/B ratio	2.01x
P/E ratio	148.15x
P/FCF ratio	22.41x
P/OCF ratio	10.46x
P/S ratio	0.57x
Price / tangible book value	2.05x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-8.96%
EBITDA margin	-6.03%
FCF margin	2.56%
Gross margin	58.47%
Operating margin	-8.96%
Pretax margin	0.34%
Profit margin	0.47%
ROA	-5.29%
ROA (5Y)	-15.54%
ROCE	-8.95%
ROE	50.27%
ROIC	-8.45%
Tax / revenue	-0.13%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	134.48%
Gross profit growth (Q)	147.88%
Gross profit growth 3Y	42.8%
Gross profit growth 5Y	28.27%
Net income growth years	1
Revenue growth	121.4%
Revenue growth (Q)	123%
Revenue growth (QoQ)	26.6%
Revenue growth 3Y	41.9%
Revenue growth 5Y	15.11%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -396,785
Depreciation and amortization	AUD 398,077
EBIT	AUD -1.2M
EBITDA	AUD -818,475
EPS	AUD 0.00
FCF per share	AUD 0.00
Financing cash flow	AUD 87,525
Free cash flow	AUD 347,245
Gross profit	AUD 7.9M
Income taxes	AUD -18,258
Investing cash flow	AUD -469,284
Net borrowing	AUD -262,475
Net cash flow	AUD 362,271
Net income	AUD 64,385
Operating income	AUD -1.2M
Revenue	AUD 13.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.91
Book value per share	AUD 0.01
Debt / equity	2.24
Debt / FCF	25.02
Interest coverage	-1.29
Long-term assets	AUD 14.6M
Long-term liabilities	AUD 9.7M
Net cash (debt)	AUD -7.4M
Net cash / market cap	-95.14%
Net debt / equity	1.91
Net debt / FCF	21.32
Piotroski F-Score	6
Property, plant and equipment	AUD 14.2M
Shareholders' equity	AUD 3.9M
Tangible book value	AUD 3.8M
Tangible book value per share	AUD 0.01
Total assets	AUD 19.5M
Total cash	AUD 1.3M
Total debt	AUD 8.7M
Total liabilities	AUD 15.6M
WACC	8.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.94
Current assets	AUD 4.8M
Current liabilities	AUD 5.9M
Current ratio	0.82
Inventory turnover	6.18
Net working capital	AUD -1.2M
Quick ratio	0.57
Working capital	AUD -1M
Working capital turnover	-5.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-8.12%
Shareholder yield	-8.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.02
1D price change	-4.76%
1M price change	-28.57%
1M total return	-28.57%
20-day SMA	AUD 0.02
3M price change	-13.04%
3M total return	-13.04%
50-day SMA	AUD 0.02
52-week high	AUD 0.04
52-week high date	2025-12-30
52-week low	AUD 0.02
52-week low date	2026-10-19
All-time high	AUD 0.04
All-time high date	2025-12-22
All-time low	AUD 0.02
All-time low date	2026-05-05
Average true range (ATR)	AUD 0.00
Average volume	82K
Beta (1Y)	-0.29
Beta (2Y)	-0.14
Beta (5Y)	0.63
Change from 52-week high	-50%
Change from 52-week low	5.26%
Change from all-time high	-50%
Change from all-time low	5.26%
Change from open	0%
Day's gap	-4.76%
Dollar volume	AUD 1,161
High price	AUD 0.02
Low price	AUD 0.02
Monthly RSI	0
Open price	AUD 0.02
Position in 52-week range	0%
Previous close	AUD 0.02
Price vs 150-day SMA	-13.42%
Price vs 20-day SMA	-16.32%
Price vs 50-day SMA	-19.03%
Relative volume	0.72
RSI	37.05
Sharpe ratio	-0.33
Sortino ratio	-0.41
Volume	58K
Weekly RSI	36.07
YTD price change	-39.39%
YTD total return	-39.39%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	241.9M
Shares change (QoQ)	-7.57%
Shares change (YoY)	8.12%
Shares held by insiders	12.78%
Shares held by institutions	9.98%
Shares outstanding	389.1M

Deeper analysis on ASX/EPN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/EPN report

Is a complete ASX/EPN research report available?

No complete published report is available for asx/EPN (ASX/EPN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/EPN (ASX/EPN)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/EPN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/EPN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/EPN

Frequently asked questions